VRTX
VRTX
NASDAQ · Biotechnology

Vertex Pharmaceuticals Inc

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$477.92
+19.11 (+4.17%)
As of Feb 12, 6:31 PM ET ·
Analyst Consensus
Strong Buy
39
Analysts
Very High
Coverage
Buy 30 77%
Hold 8 21%
Sell 1 3%
Price Target
Analyst Price Target -8.3% upside
Low Target $313.95
Average Target $438.34
High Target $454.41
Current Price $477.92
Current
$477.92
Target
$438.34
$313.95 $438.34 avg $454.41
Scenario Analysis
Bear Case
$313.95
-34.3%
Low target
Base Case
$438.34
-8.3%
Avg target
Bull Case
$454.41
+-4.9%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$519.68
-8.0% from high
52-Week Low
$362.50
+31.8% from low
50-Day SMA
$456.37
+4.7% vs SMA
200-Day SMA
$436.20
+9.6% vs SMA
RSI (14)
69.4
Neutral
Target vs 52W High
$438.34
-15.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%